<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883673</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-PIVOTAL-1.0</org_study_id>
    <nct_id>NCT02883673</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of the InPress Device in Treating Primary Postpartum Hemorrhage</brief_title>
  <official_title>Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Performance of the InPress Device in Treating Primary Postpartum Hemorrhage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InPress Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InPress Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and effectiveness of the InPress Device
      in the control and reduction of primary postpartum hemorrhage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This IDE study is designed to evaluate the effectiveness and safety of the InPress Device to
      treat primary PPH. The study in literature controlled.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy: Cessation of uterine hemorrhaging</measure>
    <time_frame>24 hrs</time_frame>
    <description>Control of postpartum hemorrhage, defined as the avoidance of non-surgical, second-line or surgical intervention to control uterine hemorrhage after the use of the InPress Device per the Instructions for Use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety: Incidence and intensity of device-related Adverse Events</measure>
    <time_frame>6 weeks</time_frame>
    <description>Incidence and intensity of device-related Adverse Events will be documented during the course of the study.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">107</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>InPress Device for Postpartum Hemorrhage will be administered to subjects who are diagnosed with postpartum hemorrhage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>InPress Device</intervention_name>
    <description>It is a teardrop-shaped, soft silicone ring that is placed into the uterus, where gentle suction is applied to cause the uterus to contract and shrink in size, compressing the blood vessels so the bleeding stops.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult Female, 18 years of age or older

          2. Able to understand and provide informed consent to participate in the study

          3. Recent vaginal or cesarean delivery followed by postpartum hemorrhage

          4. Clinical estimate of blood loss within 24 hours after birth per the World Health
             Organization (&quot;WHO&quot;) guidelines for diagnosis of Primary Postpartum Hemorrhage of
             greater than or equal to 500 ml for vaginal delivery or 1000 ml for a Cesarean
             delivery

          5. Failed first-line intervention of uterotonics and uterine massage/bimanual compression
             to stop bleeding

        Exclusion Criteria:

          1. Minor (less than 18 years of age)

          2. Unable to understand and provide consent to participate in the study

          3. Delivery at a uterus size &lt; 34 weeks

          4. For Cesarean section subjects: Cervix &lt; 3 cm dilated at the time of the decision to
             perform a Cesarean section

          5. Loss of 1500 ml or more blood

          6. Arterial bleeding requiring surgical exploration or angiographic embolization

          7. Cases requiring immediate life-saving hysterectomy

          8. Untreated uterine anomaly

          9. Ongoing intrauterine pregnancy

         10. Retained placenta or placenta delivered incomplete unless the bulk of placenta has
             been removed, and no further placental tissue can be retrieved by a choice of manual
             and/or curettage intervention

         11. Uterine rupture or dehiscence

         12. Uterine inversion (uterine fundus not felt abdominally or is visible in vagina)

         13. Subject has undergone balloon therapy for PPH prior to use of the InPress Device.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary D'Alton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Perinatal Research Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathryn D Wine, MPH</last_name>
    <phone>415-990-4104</phone>
    <email>kathryn@inpresstechnologies.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Texas Medical Branch</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Salazar</last_name>
      <email>assalaza@utmb.edu</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Chiossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Gibson</last_name>
      <phone>801-213-2845</phone>
      <email>Marie.Gibson@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Karen Gibbins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital - Nsambya</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Othiniel Musana</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008 Dec;22(6):999-1012. doi: 10.1016/j.bpobgyn.2008.08.004. Epub 2008 Sep 25. Review.</citation>
    <PMID>18819848</PMID>
  </reference>
  <reference>
    <citation>Khan KS, Wojdyla D, Say L, GÃ¼lmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006 Apr 1;367(9516):1066-74. Review.</citation>
    <PMID>16581405</PMID>
  </reference>
  <reference>
    <citation>McLintock C, James AH. Obstetric hemorrhage. J Thromb Haemost. 2011 Aug;9(8):1441-51. doi: 10.1111/j.1538-7836.2011.04398.x. Review.</citation>
    <PMID>21668737</PMID>
  </reference>
  <reference>
    <citation>American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006 Oct;108(4):1039-47.</citation>
    <PMID>17012482</PMID>
  </reference>
  <reference>
    <citation>Schorn MN. Measurement of blood loss: review of the literature. J Midwifery Womens Health. 2010 Jan-Feb;55(1):20-7. doi: 10.1016/j.jmwh.2009.02.014. Review.</citation>
    <PMID>20129226</PMID>
  </reference>
  <reference>
    <citation>Sapadin AN, Lebwohl MG, Teich SA, Phelps RG, DiCostanzo D, Cohen SR. Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks--apparent regression with hemodialysis. J Am Acad Dermatol. 1998 Aug;39(2 Pt 2):338-44. Review.</citation>
    <PMID>9703148</PMID>
  </reference>
  <reference>
    <citation>Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG. 2008 Sep;115(10):1265-72. doi: 10.1111/j.1471-0528.2008.01859.x.</citation>
    <PMID>18715412</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postpartum Hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

